Recombinant human growth hormone (rhGH) products are currently approved to treat multiple growth disorders, including pediatric and adult growth hormone deficiency, Turner Syndrome, chronic renal insufficiency, idiopathic short stature, Prader-Willi Syndrome, short children born small for gestational age, short bowel syndrome and muscle wasting in patients with HIV.
Basic scientists and endocrinologists report on advances in clinically relevant topics related to growth, pediatric and adult growth hormone deficiency, metabolic disorders, diabetes mellitus, and neurology.
for the development, manufacture and worldwide commercialization of two next-generation growth hormone products, containing Genentech's recombinant human growth hormone Nutropin AQ[R] and Tercica's recombinant human IGF-1 Increlex([R]) for the treatment of short stature, adult growth hormone deficiency (AGHD), and potentially other metabolic disorders.
Combination Products for the Potential Treatment of Short Stature and Adult Growth Hormone Deficiency Tercica May Receive up to $53 Million in Equity Payments, Opt-in Payments, R&D Reimbursement and Milestone Payments from Genentech Pending FDA guidance, Tercica intends to initiate Phase II Clinical Trials in 2008 BRISBANE, Calif.
for severe Primary IGF-1 Deficiency and the following indications: Primary IGF-1 Deficiency, Noonan's Syndrome, Laron Syndrome, Growth Hormone Deficiency, and all other short stature indications; and Adult Growth Hormone Deficiency.
Recombinant human growth hormone (rhGH) products are currently approved to treat multiple growth disorders, including pediatric and adult growth hormone deficiency, Turner Syndrome, chronic renal insufficiency, idiopathic short stature, Prader-Willi Syndrome, short children born small for gestational age, short bowel syndrome and muscle wasting in patients with HIV.
Recombinant human growth hormone (rhGH) products are currently approved to treat multiple growth disorders, including pediatric and adult growth hormone deficiency, Turner Syndrome, chronic renal insufficiency, idiopathic short stature, Prader-Willi Syndrome, short children born small for gestational age, short bowel syndrome and muscle wasting in patients with HIV.
